Estrogen receptors and cell proliferation in breast cancer

Trends in Endocrinology and Metabolism

Volumn 8, Issue 8, 1997, Pages 313-321

  Ciocca, Daniel R ^a   Fanelli, Mariel A ^a  

^a Laboratorio de Reproduccion y Lactancia Mendoza   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR;

BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GROWTH; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; GROWTH STIMULATION; HUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR DENSITY; REVIEW;

EID: 0030712873     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(97)00122-7     Document Type: Review

References (62)

1. Aizu-Yokota E, Ichinoseki K, Sato Y: 1994. Microtubule disruption induced by estradiol in estrogen receptor-positive and -negative human breast cancer cell lines. Carcinogenesis 15:1875- 1879.
2. Aronica SM, Kraus WL, Katzenellenbogen BS: 1994. Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 91:8517-8521.
3. 1 can induce estrogen-independent tumorigenicity of human breast cancer cells in athymic nude mice. Cell Growth Differ 4:193-201.
4. Ballare C, Bravo AI, Laucella S, et al.: 1989. DNA synthesis in estrogen receptor-positive human breast cancer takes place preferentially in estrogen receptor negative cells. Cancer 64:842-848.
5. Barinaga M: 1995. A new twist to the cell cycle. Science 269:631-632.
6. Beato M, Sanchez-Pacheco A: 1996. Interaction of steroid hormone receptors with the transcription initiation complex. Endocr Rev 17:587-597.
7. Brunner N, Bronzert D, Vindelov LL, Rygaard K, Spang-Thomsen M, Lippman ME: 1989. Effect on growth and cell cycle kinetics of estradiol and tamoxifen on MCF-7 human breast cancer cells grown in vitro and in nude mice. Cancer Res 49:1515-1520.
8. Calaf G, Alvarado ME, Russo J: 1995. Influence of lobular development on breast epithelial cell proliferation and steroid receptor content [abst no. A3724]. Proc Am Assoc Cancer Res 36:626.
9. Campani D, Sarnelli R, Fontanini G, et al.: 1993. Receptor status, proliferating activity, and c-erbB2 oncoprotein: an immunocytochemical evaluation in breast cancer. Ann NY Acad Sci 698:167-173.
10. Ciocca DR, Vargas Roig LM: 1995. Estrogen receptors in human nontarget tissues: biological and clinical implications. Endocr Rev 16:35-62.
11. Ciocca DR, Vargas Roig LM, Fanelli MA: 1994. Estrogen receptors in the human female genital tract in normal and pathological conditions. Biocell 18:1-21.
12. Clevenger CV, Chang WP, Ngo W, Pasha TL, Montone KT, Tomaszewski JE: 1995. Expression of prolactin and prolactin receptor in human breast carcinoma: evidence for an autocrine/paracrine loop. Am J Pathol 146:695-705.
13. Das R, Vonderhaar BK: 1996. Activation of raf-1, MEK, and MAP kinase in prolactin responsive mammary cells. Breast Cancer Res Treat 40:141-149.
14. Dean DM, Sanders MM: 1996. Ten years after: reclassification of steroid-responsive genes. Mol Endocrinol 10:1489-1495.
15. Dickson RB, Lippman ME: 1995. Growth factors in breast cancer. Endocr Rev 16:559-587.
16. Di Domenico M, Castoria G, Bilancio A, Migliaccio A, Auricchio F: 1996. Estradiol activation of human colon carcinoma-derived Caco-2 cell growth. Cancer Res 56: 4516-4521.
17. Dinda S, Khattree N, Hurd C, Jhanwar SC, Moudgil VK: 1997. Estradiol regulation of proliferation of T47D breast cancer cells: alterations in p53 tumor suppressor protein and mRNA levels [abst no. A1970]. Proc Am Assoc Cancer Res 38:294.
18. El-Ashry D, Chrysogelos SA, Lippman ME, Kern FG: 1996. Estrogen induction of TGF-α is mediated by an estrogen response element composed of two imperfect palindromes. J Steroid Biochem Mol Biol 59: 261-269.
19. Fanelli MA, Vargas Roig LM, Gago FE, et al.: 1996. Estrogen receptors, progesterone receptors, and cell proliferation in human breast cancer. Breast Cancer Res Treat 37: 217-228.
20. Foster JS, Wimalasena J: 1996. Estrogen regulates activity of cyclin-dependent kinases and retinoblastoma protein phosphorylation in breast cancer cells. Mol Endocrinol 10:488-498.
21. Fuqua SAW, Fitzgerald SD, Chamness GC, et al.: 1991. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 51:105-109.
22. Galaktionov K, Beach D: 1991. Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell 67:1181-1194.
23. Gudas JM, Klein RC, Oka M, Cowan KH: 1995. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells. Clin Cancer Res 1:235-243.
24. Han X, Liehr JG: 1994. 8-hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res 54:5515-5517.
25. Herrera RE, Makela TP, Weinberg RA: 1996. TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. Mol Biol Cell 7:1335-1342.
26. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L: 1996. Nuclear receptor coactivators and corepressors. Mol Endocrinol 10:1167-1177.
27. Huynh H, Yang X-F, Pollak M: 1996. A role for insulin-like growth factor binding protein 5 in the antiproliferative action of the antiestrogen ICI 182780. Cell Growth Differ 7:1501-1506.
28. Ingle JN, Foley JF, Mailliard JA, et al: 1994. Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer. Cancer 73: 2337-2343.
29. Katzenellenbogen JA, O'Malley BW, Katzenellenbogen BS: 1996. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 10:119-131.
30. Laidlaw IJ, Clarke RB, Howell A, Owen AWMC, Potten CS, Anderson E: 1995. The proliferation of normal human breast tissue implanted into athymic nude mice is stimulated by estrogen but not progesterone. Endocrinology 136:164-171.
31. Landel CC, Kushner PJ, Greene GL: 1994. The interaction of human estrogen receptor with DNA is modulated by receptor-associated proteins. Mol Endocrinol 8:1407-1419.
32. Lee AV, Weng C-N, Jackson JG, Yee D: 1997. Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells. J Endocrinol 152:39-47.
33. Malarkey WB, Kennedy M, Allred LE, Milo G: 1983. Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. J Clin Endocrinol Metab 56:673-677.
34. Marchetti E, Querzoli P, Marzola A, et al.: 1990. Assessment of proliferative rate of breast cancer by Ki67 monoclonal antibody. Modern Pathol 3:31-35.
35. Marks JR, Huper G, Vaughn JP, et al.: 1997. BRCA1 expression is not directly responsive to estrogen. Oncogene 14:115-121.
36. Martin JL, Coverley JA, Pattison ST, Baxter RC: 1995. Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. Endocrinology 136:1219-1226.
37. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JSV: 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669.
38. McInerney EM, Ince BA, Shapiro DJ, Katzenellenbogen BS: 1996. A transcriptionally active estrogen receptor mutant is a novel type of a dominant negative inhibitor of estrogen action. Mol Endocrinol 10: 1519-1526.
39. Metzger DL, Kerrigan JR, Rogol AD: 1994. Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans: mechanisms of androgen and estrogen action. Trends Endocrinol Metab 5:290-296.
40. Nielsen NH, Emdin SO, Cajander J, Landberg G: 1997. Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein. Oncogene 14:295-304.
41. Otto AM: 1995. A one minute pulse of estradiol to MCF-7 breast cancer cells changes estrogen receptor binding properties and commits cells to induce estrogenic responses J Steroid Biochem Mol Biol 54:39-46.
42. Papa V, Costantino A, Belfiore A: 1997. Insulin receptor: what role in breast cancer? Trends Endocrinol Metab 8:306-312.
43. Pike MC, Spicer DV, Dahmoush L, Press MF: 1993. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17-35.
44. Potthoff SJ, Romine LE, Nardulli AM: 1996. Effects of wild type and mutant estrogen receptors on DNA flexibility, DNA bending, and transcription activation. Mol Endocrinol 10:1095-1106.
45. Pratt SE, Pollak MN: 1993. Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specific alterations in accumulation of insulin-like growth factor-binding proteins in conditioned media. Cancer Res 53:5193-5198.
46. Rishi AK, Shao Z-M, Baumann RG, et al.: 1995. Estradiol regulation of the human retinoic acid receptor a gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 55:4999-5006.
47. Rochefort H, Capony F, Garcia M, Veith F, Vignon F, Westley B: 1984. Estrogen-induced proteins in human breast cancer cells. Recent Res Cancer Res 91:289-294.
48. Rostagno P, Caldani C, Lahlou B: 1996. Cell cycle expression of steroid receptors determined by image analysis on human breast cancer cell line: a hypothesis on the effects of antiestrogens. Breast Cancer Res Treat 37:77-87.
49. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL: 1995. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid. Endocrinology 136:1296-1302.
50. Russell KS, Hung MC: 1992. Transcriptional repression of the neu protooncogene by estrogen stimulated estrogen receptor. Cancer Res 52:6624-6629.
51. wt5 cells transfected with ER gene [abst no. 1327]. Proc Am Assoc Cancer Res 38:197.
52. Seymour L, Bezwoda WR, Meyer K, Behr C: 1990. Detection of P24 protein in human breast cancer: influence of receptor status and oestrogen exposure. Br J Cancer 61: 886-890.
53. Sheikh MS, Garcia M, Pujol P, Fontana JA, Rochefort H: 1994. Why are estrogen-receptor-negative breast cancers more aggressive than the estrogen-receptor-positive breast cancers? Invasion Metastasis 95:329-336.
54. Sherr CJ: 1996. Cancer cell cycles. Science 274:1672-1677.
55. Silberstein GB, Van Horn K, Shyamala G, Daniel CW: 1994. Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 134:84-90.
56. Stillman B: 1996. Cell cycle control of DNA replication. Science 274:1659-1664.
57. Thomas T, Thomas TJ: 1994. Regulation of cyclin B1 by estradiol and polyamines in MCF-7 breast cancer cells. Cancer Res 54: 1077-1084.
58. Wang TTY, Phang JM: 1995. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res 55: 2487-2489.
59. Webb P, Lopez GN, Greene GL, Baxter JD, Kushner PJ: 1992. The limits of the cellular capacity to mediate an estrogen response. Mol Endocrinol 6:157-167.
60. Weigel RJ, Crooks DL, Iglehart JD, deConinck EC: 1995. Quantitative analysis of the transcriptional start sites of estrogen receptor in breast carcinoma. Cell Growth Differ 6:707-711.
61. Weinstein IB: 1991. Mitogenesis is only one factor in carcinogenesis. Science 251:387-388.
62. Zhang Q-X, Hilsenbeck SG, Fuqua SAW, Borg A: 1996. Multiple splicing variants of the estrogen receptor are present in individual human breast tumors. J Steroid Biochem Mol Biol 59:251-260.